La gestione dei #pazienti con #tumoredelrene in stadio precoce sarà al centro del prossimo #mercoledidelloncologia. Iscrizioni qui: aiomservizifad.it/appuntamenti-a…

❇️ From #NOresponse to #NOrelapse AIOM Società Italiana di Urologia 🇮🇹 #RCC #AdjTherapy #DFS #OS Kidney Cancer IKCC Kidney Cancer 🧡💚

Today world microbioma day:great meeting focused on a top medical issue

Questa mattina ad #Health di Sky tg24, focus sul tumore della prostata. Ospite Giuseppe Procopio , presidente Meeturo.

🌟 #MeetTheEditors Genitourinary Oncology Section of TJ, led by dr. Giuseppe Giuseppe Procopio , dr. Patrizia Patrizia Giannatempo and dr. Marcello Tucci, is focused on evaluation of articles on detection, diagnosis, prevention and treatment of genitourinary tumors, promoting studies

𝐂𝐈 𝐒𝐈𝐀𝐌𝐎 𝐏𝐑𝐄𝐒𝐈 𝐈𝐋 𝐓𝐄𝐌𝐏𝐈𝐎 𝐃𝐄𝐋 𝐓𝐄𝐍𝐍𝐈𝐒 🇮🇹🌱 #Tennis #Wimbledon #Sinner

New real-world evidence for older #mRCC patients! We explored the effectiveness of nivolumab-based #immunotherapy and how the MeetURO score can refine prognosis, supporting treatment decisions. Full article here: sciencedirect.com/science/articl…  #CancerResearch #oncology #Genitourinary

The online #FAD course (5 ECM credits) on "modern #multidisciplinary approach to #renal #cancer" promoted by Società Italiana di Urologia is online To register: 👉ecm.siu.it/front/single/2… 🎓Several experts from multiple specialties 🇮🇹 Italian language 📆Accessible until June 2026 📺Video

The #THOR2 trial confirms the efficacy of #Erdafitinib for patients with FGFR3/2alt-altered HR- or IR- #NMIBC. A promising step forward in personalized #BladderCancer care. #Clinicalresearch #Oncology #Genitourinary #PrecisionMedicine Full article here authors.elsevier.com/sd/article/S03…

La Fondazione IRCCS Istituto Nazionale dei Tumori di Milano sempre all'avanguardia per ricerca,cura,scienza ed umanità #ricerca #cura #umanizzazione #scienza

Bone Health and Body Composition as Predictive and Prognostic Markers in Metastatic Castration-resistant Prostate Cancer: A Meet-URO Narrative Review. Doi: doi.org/10.1016/j.clgc… Anna Amela Valsecchi #meeturo #clinicalgenitourinarycancer

Real-world evidence on Cabozantinib as first-line therapy for metastatic renal cell carcinoma from the CabFRONT Study (Meet-URO 24). 👉 Read the full article: authors.elsevier.com/sd/article/S26… #ClinicalResearch #Oncology #Genitourinary #mRCC #RealWorldData #MeetURO

Esmo 2025:meeting with my friend Toni Choueri

Il paradigma di cura del #tumoredellavescica muscolo-invasivo potrebbe cambiare: a dirlo sono i risultati dello studio di Fase III #KEYNOTE-905, presentati ad #ESMO25. L’articolo: medinews.it/comunicati/tum…

Even within the same country (Italy), use of off-label cancer drugs is subject to significant inter-hospital variability. This leads to potential disparities in patients' access to care. Have a look at the project by AIOM, just published on Tumori Journal: journals.sagepub.com/eprint/VXIKKBV…

Kudos to Elena Verzoni on a terrific talk on imaging in #kidneycancer & #bladdercancer at #ESMO25! A tough topic well encompassed in 20 min, with citations of the pivotal work in this space by @kidneycancerdoc.

23 years of f/u of perhaps the best screening study in prostate cancer. Still, many debates on who to screen and what age, but Andrew Vickers does a good job putting ERSPC into perspective in his NEJM editorial.

Katie Coleman Elizabeth Plimack MD Cristiane D Bergerot, PhD, FASCO Nazli Dizman Bradley McGregor Giuseppe Procopio Benjamin L Maughan Salvatore La Rosa Giannicola Genovese MD, PhD Jason A. Mouabbi MD Linghua Wang, MD, PhD Omar Alhalabi, MD Luigi Perelli Rahul Sheth Chad Tang, MD Tian Zhang, MD, MHS, FASCO (@tiansterzhangmd.bsky) Qing Zhang Brittney Cotta, MD Dan George Daniel Heng Priya Rao, MD Ashish M. Kamat, MD, MBBS ROHIT MEHRA Eleonora Dondossola,PhD Daniel E. Frigo, Ph.D. Samson W. Fine, MD Katy Beckermann Shilpa Gupta Amanda Nizam, MD Ziad Bakouny, MD, MSc 5/5 Clinical evidence: Sacituzumab govitecan in 4 heavily pretreated RMC pts → 1 PR (~5.3 mo) + 2 SD; median PFS 2.9 mo. Early, small-n but proof that biology-guided targeting can bend the curve for RMC.  Next: more RMC-specific trials based on these biological insights.

Congresso Meeturo Young Catanzaro 30-31/10/2025 Giuseppe Procopio

Two intense days filled with research, discussion, and human connections that truly make a difference #kidneycancerresearch #renalcellcarcinoma